Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1CNS 1Breast 1

Conditions

Myelodysplastic Syndromes 57Leukemia, Myeloid, Acute 53Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Myeloproliferative Disorders 24Leukemia 24Primary Myelofibrosis 22Leukemia, Myelomonocytic, Chronic 19Lymphoma, Non-Hodgkin 18Leukemia, Lymphocytic, Chronic, B-Cell 18Hodgkin Disease 16Lymphoma, Follicular 15Multiple Myeloma 14Lymphoma, Mantle-Cell 14Lymphoma, B-Cell, Marginal Zone 14Leukemia, Myeloid, Chronic-Phase 14Burkitt Lymphoma 14Polycythemia Vera 13Lymphoma, Large B-Cell, Diffuse 12Lymphoma 12Leukemia, Myeloid, Accelerated Phase 12Lymphoma, Large-Cell, Immunoblastic 11Hematologic Neoplasms 11Congenital Abnormalities 11Blast Crisis 11Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10Sezary Syndrome 9Recurrence 9Pdgfra-Associated Chronic Eosinophilic Leukemia 9Mycosis Fungoides 9

Interventions

Mitoxantrone 1Cytarabine 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Drug-Related Side Effects and Adverse Reactions × Myeloid × Clear all
NCT00003407 2023-02-02

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Rush University Medical Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡